Wells Fargo & Company »

Moleculin Biotech shares owned by Wells Fargo & Company

Quarter-by-quarter ownership of Moleculin Biotech (MBRX) shares owned by Wells Fargo & Company from 13F filings

Historical chart of Wells Fargo & Company investment in Moleculin Biotech

Tip: Access up to 7 years of quarterly data

All positions including Moleculin Biotech held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Moleculin Biotech by Wells Fargo & Company

Quarter filed Position value Share count Share price at filing
2026-06-30 $558 200 2.79

More positions owned by Wells Fargo & Company

Apple Call Option (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
Microsoft Corporation (MSFT)
NVIDIA Corporation Put Option (NVDA)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Tr Core S&p Ttl Stk (ITOT)
Broadcom (AVGO)
Vanguard Index Fds Mid Cap Etf (VO)
Amazon (AMZN)
Ishares Tr Core Msci Eafe (IEFA)
Ishares Tr Russell 2000 Etf Put Option (IWM)
JPMorgan Chase & Co. (JPM)
Ishares Core Msci Emkt (IEMG)

View all positions for Wells Fargo & Company

Top funds holding Moleculin Biotech

Geode Capital Management
Vanguard Capital Management
Vanguard Fiduciary Trust
XTX Topco
Rockefeller Capital Management
Tower Research Capital
Barclays
BlackRock
EFG International
Jones Financial Companies, L.L
Wells Fargo & Company
Newbridge Financial Services Group
SBI Securities
Morgan Stanley
Danske Bank A/s

View all funds holding Moleculin Biotech